Physician profile
Amy E Prince
NPI 1699345751
$1,950.58
in general payments reported to CMS, 2019-2025
22 companies · $637 in 2025
The $637 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $457 · 2022: $434 · 2023: $104 · 2024: $319 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $641.14 | 2021-2025 | |
| Heartflow, INC. | $120.81 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $118.37 | 2022-2025 | Lifevest |
| Boston Scientific Corporation | $118.23 | 2023-2025 | Watchman Flx, Bodyguardian |
| Sunovion Pharmaceuticals INC. | $104.46 | 2021-2022 | |
| Novo Nordisk INC | $100.09 | 2021-2025 | Wegovy |
| Esperion Therapeutics, INC. | $92.79 | 2021 | |
| Biogen, INC. | $89.99 | 2021-2022 | |
| Amgen INC. | $85.04 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $84.70 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $65.63 | 2024-2025 | Eliquis, Camzyos |
| Lilly USA, LLC | $51.88 | 2021-2022 | |
| Abbvie INC. | $45.31 | 2022 | |
| Pfizer INC. | $40.42 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.96 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $34.04 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.98 | 2022 | |
| Merck Sharp & Dohme LLC | $28.25 | 2021-2022 | |
| Medtronic, INC. | $20.26 | 2022 | |
| Scpharmaceuticals INC. | $17.73 | 2023 | |
| Eisai INC. | $12.83 | 2021 | |
| Amarin Pharma, INC. | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Prince listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.